Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland.

Johanna J ZirpelIsabel B PfisterChristin GerhardtJustus Gerhard Garweg

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)

A greater visual gain, in response to more intensive treatment during the first year, was maintained for at least 5 years in group 2 subjects. Our data confirm that in a real-world setting, early intensive treatment results in satisfying long-term visual outcomes.

Keyphrases

diabetic retinopathy
type diabetes
vascular endothelial growth factor
electronic health record
machine learning
big data
endothelial cells
artificial intelligence
replacement therapy